ISLAMABAD: Capital Hospital CDA Islamabad organised a multidisciplinary awareness programme on Polyendocrine Metabolic-Ovarian Syndrome (PMOS) under the auspices of the Department of Endocrinology on September 16, 2026.
The programme, titled “Healthy Her, Healthy Us — Healthy Women, Stronger Society”, was held under the supervision of Dr Sarwar Malik, Head of the Department of Endocrinology, and in the presence of Executive Director CDA Hospital Dr Muhammad Naeem Taj.
The event was organised and moderated by Dr Aimen Malik, who highlighted the evolving concept of PMOS. She discussed the rationale for moving beyond the traditional PCOS (Polycystic Ovary Syndrome) terminology to underline the broader endocrine, metabolic, ovarian and systemic dimensions of the condition.
Specialists from Endocrinology, Medicine, Gynecology, Dermatology, Psychiatry, Radiology and Nutrition attended the programme, reflecting the multidisciplinary nature of PMOS.
Dr Saira Bashir, Endocrinologist, spoke on the comprehensive medical treatment and management of PMOS.
From the Department of Gynecology, Dr Sheeba Noreen, HOD Gynecology, and Dr Arooj, Gynecologist, discussed the reproductive and clinical aspects of PMOS. Dr Hadia Aziz, Gynecologist, delivered a talk on weight bias and its impact on women with PMOS, emphasising respectful, patient-centred and stigma-free care.
Dr Uzma Ali, HOD Dermatology, CDA, discussed dermatological manifestations and clinical recognition of PMOS. Dr Fatima Bilal, HOD Psychiatry, CDA, highlighted the importance of mental health, emotional well-being and behavioural aspects of the condition.
Ms Mehwish, Nutritionist, CDA, emphasised nutrition, physical activity, healthy weight management and sustainable lifestyle modification.
Dr Saba Hafeez, Consultant Endocrinologist from Shifa International Hospital, delivered an informative talk on prevention, early diagnosis and timely management of PMOS. Dr Shazia, HOD Radiology, CDA, was also present, along with HODs, consultants and healthcare professionals from various departments.
The speakers said PMOS involves an interconnected spectrum of endocrine dysfunction, metabolic abnormalities, ovarian dysfunction, hyperandrogenic manifestations and associated reproductive, dermatological and psychological concerns.
They emphasised early recognition of metabolic risk factors, individualised management, lifestyle intervention, appropriate medical therapy and long-term follow-up.
As part of the awareness initiative, PMOS awareness leaflets covering symptoms, prevention, lifestyle modification, diagnosis and treatment were distributed among participants.
The programme provided a multidisciplinary platform for promoting evidence-based awareness, reducing stigma and encouraging timely diagnosis and comprehensive care for women’s endocrine and metabolic health.
